Connect with us


Seven Things to Consider When Choosing an Egg Donor




If you are considering using an egg donor to conceive a child, there are many things to consider. You need to find an egg donor who is compatible with you and your partner, and who has the characteristics that you are looking for.

Here are seven things to think about when choosing an egg donor:

1. Compatibility: It is important to find an egg donor whose genetic background and health history match up with yours and your partner’s. Be sure to ask questions about the medical history of the potential donor, such as any past or present illnesses, family medical history, and any medications they may be taking.

2. Health Screenings: Make sure that the egg donor has undergone all necessary health screenings and tests prior to donating their eggs. This will help ensure that you are receiving healthy eggs from a qualified donor.

3. Lifestyle Habits: Inquire about the potential donor’s lifestyle habits such as diet, exercise, drug use, alcohol consumption, and smoking; these may affect fertility or preconception health in the long run.

4. Education Level: Ask the egg donor about their educational background and any professional qualifications they have; this will help you determine whether or not they are capable of providing informed consent to the donation process.

5. Age and Previous Donations: The age of the donor may also play a role in the quality of the eggs and it is important to know how many times the donor has previously donated eggs, as this can affect their fertility.

6. Personality: Consider the personality traits that you would like your child to possess and make sure that these qualities are reflected in the potential egg donor.

7. Professionalism: Make sure that you feel comfortable with both the egg donation agency and the egg donor. Be sure to ask questions and get to know them before making a final choice.

Choosing an egg donor is a big decision, but finding an egg donor is not a very difficult task if you know the right steps to take. So make sure you do your research and take the time to pick the best option for you. With careful consideration and proper preparation, finding an egg donor can help you bring your dream of parenthood into reality.

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


The Most Compatible Solution to the Human Body from Turkish Scientists for Joint Pains Warned by The World Health Organization!




Degeneration of the joints significantly complicates daily life.

The World Health Organization (WHO) predicts that by 2050, 130 million people worldwide will suffer from joint pain and osteoarthritis. According to the World Health Organization, by 2050, 40 million people will lose function due to osteoarthritis.

The USA is the country with the highest prevalence of osteoarthritis in the world. More than half (18.7 million people) of adults with osteoarthritis in the United States are of working age (18-64 years). For this reason, osteoarthritis also causes a significant loss of workforce.

Against joint pain and osteoarthritis Scientists have made an important discovery. Developed with hybrid technology, HYDRAVIC received full marks from health authorities.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.


Against joint pain and osteoarthritis, which the world is looking for a cure for, scientists have made an innovative development in intra-articular fluids. Turkish scientists have developed an intra-articular injection with the most compatible gel form with the hybrid production technology. The product, which was launched under the HYDRAVIC brand, attracts great attention all over the world.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.


HYDRAVIC, one of the first intra-articular injections with hybrid production technology in Turkey, stands out with its patient satisfaction. Stating that HYDRAVIC minimizes the wear on the cartilage and slows down the pressure created by the body on the cartilage, Prof. Dr. Serdar Sezer said, “HYDRAVIC was developed with inspiration from the complex structure of hyaluronic acid in the body. Patient satisfaction is quite good. Hybrid technology is a system that has been applied for the first time in Turkey, like its examples in the world. HYDRAVIC prevents patients from complaining of pain for up to 6-8 months.” 


Drawing attention to the importance of hybrid technology used in the production of HYDRAVIC, Professor Serdar Sezer “One of the features of hybrid technology is that it creates a triggering effect for the product to produce hyaluronic acid while being excreted from the body. This has been demonstrated in in-vitro and in-vivo experiments. Clinical long-term responses are very good. In our studies while developing these products, we have observed studies that have a longer duration of action with our innovative approach that repeats the results proven in the world. After its effectiveness has been proven, we are happy to introduce such a product to the market in the injection market, where we are one of the leading manufacturers in the field. We apply similar approaches across all our product models.” uses expressions.

Stating that they minimize the pain experienced by the patients during the injection, Professor Sezer said, “What makes HYDRAVIC different from other products is its technology. It is a product that does not make the patient feel very low or no pain during the injection and relieves the patient’s pain in a short time. In this technology, in addition to the molecular interaction, post-injection pain and swelling, etc., due to the production of the product in aseptic technical infrastructure. We minimize such complaints as possible.”


Stating that Europe’s largest pharmaceutical and medical device R&D Center in the field of biomaterials was established in Turkey, Professor Sezer said, “To produce these kinds of products, the well-equipped infrastructures are required very serious costs. Many companies do not want to invest in such product groups, which have high infrastructure costs and are difficult to produce. With the new legislation, the costs increase significantly. We reach an annual capacity of 5.4 million units in 2023 in the HYDRAVIC production line, where we have achieved great success in the medical market.” he said.

Continue Reading